A Study on the Effection of Potassium Citrate Extended-release Tablets on Urolithiasis Formation or Recurrence

Condition:   Urolithiasis Intervention:   Drug: Potassium Citrate Extended-release Tablets Sponsor:   Dawnrays Pharmaceutical (Holdings) Limited Recruiting - verified December 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials